Prognostic impact of high p16/cyclin D1 index in breast cancer

被引：1

作者：

Kim, Gi Jeong ^{[1
,2
]}

Kim, Dong-Hoon ^{[3
]}

Min, Kyueng-Whan ^{[4
]}

Kim, Se Hoon ^{[5
]}

机构：

[1] Gachon Univ, Gil Med Ctr, Dept Pathol, Coll Med, Incheon, South Korea

[2] Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea

[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, 29 Saemunanro, Seoul 03181, South Korea

[4] Hanyang Univ, Guri Hosp, Dept Pathol, Coll Med, Guri, Gyeonggi Do, South Korea

[5] Yonsei Univ, Severance Hosp, Dept Pathol, Coll Med, Seoul, South Korea

来源：

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2019年 / 12卷 / 06期

关键词：

Breast cancer; p16; cyclin D1; index; prognosis; CYCLIN D1; RETINOBLASTOMA PROTEIN; P16; PROTEINS; EXPRESSION; OVEREXPRESSION; CARCINOMA; METHYLATION; RB; PROGRESSION; P16(INK4A);

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Proteins p16 and cyclin D1 (CCND1) are known to tightly regulate the G1/S transition during the cell cycle, but their role in breast cancer development and progression is not clear. We investigated 224 cases of breast cancer from the Kangbuk Samsung Medical Center between 2000-2005. Expression levels of p16 and CCND1 were assessed by tissue microarray-based immunohistochemistry. A p16/CCND1 index was divided into low- and high-expression groups using receiver operating characteristic curves. The p16/CCND1 index was significantly different across molecular subtypes and a high p16/CCND1 index was statistically correlated with survival rates. This p16/CCND1 index may be an indicator of poor patient outcome and thus, represents a potential therapeutic target.

引用

页码：2224 / 2232

页数：9

共 50 条

[21] Cyclin D1 in breast cancer
Barnes, DM
Gillett, CE
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 1 - 15
[22] Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas
Michaud, Karine
de Tayrac, Marie
D'Astous, Myreille
Paquet, Claudie
Gould, Peter Vincent
Saikali, Stephan
PLOS ONE, 2018, 13 (02):
[23] Immunohistochemical Expression of Cyclin D1 and p16 in Invasive Breast Carcinoma and Its Association with Clinicopathological Parameters
Malik, Shaivy
Shakthivel, V.
Ahuja, Sana
Ahluwalia, Charanjeet
INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (04) : 864 - 873
[24] 胃癌p16和cyclin D1的表达及意义
王强修
马金龙
王家耀
中华病理学杂志, 2001, (04) : 44 - 44
[25] 胆囊癌组织p16和cyclin D1表达
马红兵
王作仁
狄政莉
石景森
王西京
空军军医大学学报, 2003, (18) : 1665 - 1667
[26] Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma
Wang, Haoxun
Wang, Jing
Zhao, Bingbo
ONCOLOGY LETTERS, 2019, 17 (06) : 4859 - 4864
[27] Expression of cyclin D1, p16 and Ki67 in prostate carcinoma
Kouvidou, Chariklia
Karpenisiotis, Grigoris
Anagnostakis, Diinitrios
Zorzos, Haralambos
Lianou, Evgenia
Karanastasis, Dirnitrios
Stravodemos, Konstantinos
Pavlaki, Kitty
VIRCHOWS ARCHIV, 2007, 451 (02) : 417 - 417
[28] 胆囊癌组织p16和cyclin D1表达
马红兵
王作仁
狄政莉
石景森
王西京
第四军医大学学报, 2003, (18) : 1665 - 1667
[29] pRb, p16, and cyclin D1 in small cell carcinoma of the uterine cervix
Horn, Lars-Christian
Hauptmann, Steffen
Leo, Cornelia
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2007, 26 (03) : 269 - 269
[30] Alterations of the Cell Cycle Regulators Cyclin D1, Cyclin A, p27, p21, p16, and pRb in Apocrine Metaplasia of the Breast
Elayat, Ghada
Selim, Abdel-Ghani A.
Wells, Clive A.
BREAST JOURNAL, 2009, 15 (05): : 475 - 482

← 1 2 3 4 5 →